Geza Acs

Summary

Affiliation: H. Lee Moffitt Cancer Center and Research Institute
Country: USA

Publications

  1. doi A mitotically active, cellular tumor stroma and/or inflammatory cells associated with tumor cells may contribute to intermediate or high Oncotype DX Recurrence Scores in low-grade invasive breast carcinomas
    Geza Acs
    Department of Anatomic Pathology, Moffitt Cancer Center, Tampa, FL 33612, USA
    Mod Pathol 25:556-66. 2012
  2. doi The extent of retraction clefts correlates with lymphatic vessel density and VEGF-C expression and predicts nodal metastasis and poor prognosis in early-stage breast carcinoma
    Geza Acs
    Department of Anatomic Pathology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA
    Mod Pathol 25:163-77. 2012
  3. doi The presence of micropapillary features and retraction artifact in core needle biopsy material predicts lymph node metastasis in breast carcinoma
    Geza Acs
    Anatomic Pathology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    Am J Surg Pathol 33:202-10. 2009
  4. ncbi Comparison of Oncotype DX and Mammostrat risk estimations and correlations with histologic tumor features in low-grade, estrogen receptor-positive invasive breast carcinomas
    Geza Acs
    1 Department of Anatomic Pathology, Comprehensive Breast Program, Moffitt Cancer Center, Tampa, FL, USA 2 Department of Women s Oncology, Comprehensive Breast Program, Moffitt Cancer Center, Tampa, FL, USA 3 Women s Pathology Consultants, Ruffolo Hooper and Associates, Tampa, FL, USA
    Mod Pathol 26:1451-60. 2013
  5. pmc The effect of Oncotype DX recurrence score on treatment recommendations for patients with estrogen receptor-positive early stage breast cancer and correlation with estimation of recurrence risk by breast cancer specialists
    Jennifer E Joh
    Department of Women s Oncology, Comprehensive Breast Program, H Lee Moffitt Cancer Center, Tampa, Florida 33612, USA
    Oncologist 16:1520-6. 2011
  6. ncbi Surgical excision of pure flat epithelial atypia identified on core needle breast biopsy
    Vanessa L Prowler
    University of South Florida, Department of Surgery, Tampa, FL 33606, USA
    Breast 23:352-6. 2014
  7. ncbi Gene expression profiling in breast cancer
    Kiran Turaga
    Department of Women s Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    Cancer Control 17:177-82. 2010
  8. doi The impact of the size of nodal metastases on recurrence risk in breast cancer patients with 1-3 positive axillary nodes after mastectomy
    Eleanor E R Harris
    Department of Radiation Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA
    Int J Radiat Oncol Biol Phys 85:609-14. 2013
  9. doi Melanocytic tumors express connexin 43 but not 26: immunohistochemical analysis with potential significance in melanocytic oncogenesis
    Michael R Sargen
    Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA Department of Neurology, Children Hospital of Philadelphia, Philadelphia, PA Department of Pathology, Moffitt Cancer Center, Tampa, FL
    Am J Dermatopathol 35:813-7. 2013
  10. pmc Connexin 43 is a potential prognostic biomarker for ewing sarcoma/primitive neuroectodermal tumor
    Marilyn M Bui
    Department of Anatomic Pathology, Moffitt Cancer Center, Tampa, FL 33612, USA
    Sarcoma 2011:971050. 2011

Collaborators

Detail Information

Publications11

  1. doi A mitotically active, cellular tumor stroma and/or inflammatory cells associated with tumor cells may contribute to intermediate or high Oncotype DX Recurrence Scores in low-grade invasive breast carcinomas
    Geza Acs
    Department of Anatomic Pathology, Moffitt Cancer Center, Tampa, FL 33612, USA
    Mod Pathol 25:556-66. 2012
    ..Careful assessment and correlation with histopathological features in such cases may help in determining the appropriate patient management...
  2. doi The extent of retraction clefts correlates with lymphatic vessel density and VEGF-C expression and predicts nodal metastasis and poor prognosis in early-stage breast carcinoma
    Geza Acs
    Department of Anatomic Pathology, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA
    Mod Pathol 25:163-77. 2012
    ....
  3. doi The presence of micropapillary features and retraction artifact in core needle biopsy material predicts lymph node metastasis in breast carcinoma
    Geza Acs
    Anatomic Pathology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    Am J Surg Pathol 33:202-10. 2009
    ....
  4. ncbi Comparison of Oncotype DX and Mammostrat risk estimations and correlations with histologic tumor features in low-grade, estrogen receptor-positive invasive breast carcinomas
    Geza Acs
    1 Department of Anatomic Pathology, Comprehensive Breast Program, Moffitt Cancer Center, Tampa, FL, USA 2 Department of Women s Oncology, Comprehensive Breast Program, Moffitt Cancer Center, Tampa, FL, USA 3 Women s Pathology Consultants, Ruffolo Hooper and Associates, Tampa, FL, USA
    Mod Pathol 26:1451-60. 2013
    ..Mammostrat, which examines cancer cells only, may provide a better estimation of likely tumor behavior in a subgroup of low-grade breast carcinomas. ..
  5. pmc The effect of Oncotype DX recurrence score on treatment recommendations for patients with estrogen receptor-positive early stage breast cancer and correlation with estimation of recurrence risk by breast cancer specialists
    Jennifer E Joh
    Department of Women s Oncology, Comprehensive Breast Program, H Lee Moffitt Cancer Center, Tampa, Florida 33612, USA
    Oncologist 16:1520-6. 2011
    ..This study has two primary endpoints: to evaluate the impact of Oncotype DX recurrence scores (RS) on chemotherapy recommendations and to compare the estimated recurrence risk predicted by breast oncology specialists to RS...
  6. ncbi Surgical excision of pure flat epithelial atypia identified on core needle breast biopsy
    Vanessa L Prowler
    University of South Florida, Department of Surgery, Tampa, FL 33606, USA
    Breast 23:352-6. 2014
    ..Pure FEA is only upgraded to cancer in 3.2% of patients. Surgical excision of pure FEA found on core needle biopsy results in overtreatment in the vast majority of breast patients and may not be necessary. ..
  7. ncbi Gene expression profiling in breast cancer
    Kiran Turaga
    Department of Women s Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    Cancer Control 17:177-82. 2010
    ..This heterogeneity has spawned an era of molecular assays striving to classify and thus predict outcome, thereby guiding the future in targeted personalized treatment strategies...
  8. doi The impact of the size of nodal metastases on recurrence risk in breast cancer patients with 1-3 positive axillary nodes after mastectomy
    Eleanor E R Harris
    Department of Radiation Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA
    Int J Radiat Oncol Biol Phys 85:609-14. 2013
    ..The objective of this study was to determine whether the size of nodal metastases in this subset could predict who would benefit from PMRT...
  9. doi Melanocytic tumors express connexin 43 but not 26: immunohistochemical analysis with potential significance in melanocytic oncogenesis
    Michael R Sargen
    Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA Department of Neurology, Children Hospital of Philadelphia, Philadelphia, PA Department of Pathology, Moffitt Cancer Center, Tampa, FL
    Am J Dermatopathol 35:813-7. 2013
    ....
  10. pmc Connexin 43 is a potential prognostic biomarker for ewing sarcoma/primitive neuroectodermal tumor
    Marilyn M Bui
    Department of Anatomic Pathology, Moffitt Cancer Center, Tampa, FL 33612, USA
    Sarcoma 2011:971050. 2011
    ..Our results suggest a possible oncogenic and prognostic role for Cx43 and Cx26 in EWS/PNET. The lack of membranous immunoreactivity suggests that the effect of Cx in EWS/PNET is via a GJ function-independent mechanism...
  11. ncbi High-risk benign breast lesions: current strategies in management
    John V Kiluk
    Comprehensive Breast Cancer Program, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    Cancer Control 14:321-9. 2007
    ..High-risk benign breast lesions can create confusion for both the patient and the clinician. This paper reviews the characteristics of these lesions to help direct appropriate management...